These studies not only surprisingly show that BRCA2 does not follow the classical Knudson “two hit” paradigm for tumour suppression, but also highlight features of the interplay between TP53 inactivation and carcinogenesis in the context of BRCA2 deficiency. This evidence concerns the gene BRCA2 and neoplasm.